4'-Methoxy-α-Pyrrolidinopentiophenone

From WikiMD's Food, Medicine & Wellness Encyclopedia

4'-Methoxy-α-Pyrrolidinopentiophenone (MOPPP) is a designer drug that belongs to the cathinone class. It is a synthetic stimulant of the amphetamine class. MOPPP is a higher homologue of 4'-Methyl-α-pyrrolidinopentiophenone (MPPP), and is often used in the research of central nervous system disorders.

Chemistry[edit | edit source]

4'-Methoxy-α-Pyrrolidinopentiophenone is a synthetic cathinone. Cathinones are a sub-category of amphetamines, which are organic compounds with a phenethylamine core. The chemical structure of MOPPP includes a phenyl ring bound to an amino (NH2) group through an ethyl chain with a ketone group at the beta carbon. It also has an additional methoxy group at the 4' position of the phenyl ring.

Pharmacology[edit | edit source]

The pharmacological properties of 4'-Methoxy-α-Pyrrolidinopentiophenone are not well-studied. However, it is known that synthetic cathinones are generally monoamine releasers. They are believed to enhance the release of monoamines like dopamine, norepinephrine, and serotonin in the brain, leading to stimulant effects.

Legality[edit | edit source]

The legality of 4'-Methoxy-α-Pyrrolidinopentiophenone varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and addiction. In the United States, it is a Schedule I controlled substance under the Controlled Substances Act.

See Also[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD